[
    [
        {
            "time": "",
            "original_text": "制药行业一周风云榜：未见开门红，CRO触底反弹，君实生物PD-1获批新适应症",
            "features": {
                "keywords": [
                    "制药行业",
                    "开门红",
                    "CRO",
                    "触底反弹",
                    "君实生物",
                    "PD-1",
                    "新适应症"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "制药",
                    "CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "制药行业一周风云榜：未见开门红，CRO触底反弹，君实生物PD-1获批新适应症",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]